Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of original research quality ceftazidime and pharmaceutical preparation thereof

A technology for ceftazidime and ceftazidime side chain acid, which is applied in the field of ceftazidime and pharmaceutical preparations thereof, can solve the problems of low yield, intractable treatment and high production cost, and achieves the effects of reducing production cost, reducing the amount of waste residue and improving product quality

Active Publication Date: 2018-01-30
广东金城金素制药有限公司 +1
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disadvantage of this method is that dichloromethane is used as the solvent, the solubility of the product is too large, the yield is low, the price of triphenylphosphine is expensive, and the production cost is high
[0008] Therefore, for the existing synthetic route of ceftazime, in the process of preparing ceftazidime side chain acid active ester and ceftazidime hydrochloride, the condensing agent triphenylphosphine that uses has high toxicity, and cost is high, and reaction by-product triphenoxyphos and DM cannot be effectively recovered, and the amount of waste water and residue is large and difficult to handle, which is not conducive to industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of original research quality ceftazidime and pharmaceutical preparation thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0031] The preparation process flow diagram of ceftazidime provided by the invention is as follows figure 1 As shown, in a mixed solvent of toluene and acetonitrile, add ceftazidime side chain acid and dibenzothiazole disulfide, then add aniline, 2-picoline in turn, and then drop triethyl phosphite to establish the preparation of ceftazidime side chain The reaction system of the active ester is suction filtered after cooling down after the reaction is completed to obtain the crude product of the ceftazidime side chain acid active ester; the crude product is refined to obtain the ceftazidime side chain acid active ester, and the first mother liquor is recovered; In the mixed solvent, add ceftazidime side chain acid active ester and 7-APCA, add triethylamine dropwise during stirring, after the reaction is completed, cool down and crystallize, obtain ceftazime tert-butyl ester by suction filtration, and recycle the second mother liquor; ceftazidime tert-butyl The ester is subject...

Embodiment 1

[0035] Control the temperature around 20°C, add 30g of ceftazidime side chain acid and 30g of DM to the mixture of 100ml of toluene and 50ml of acetonitrile, add 8.0g of aniline, 0.4g of 2-methylpyridine in turn, and then dropwise add 4.5g of triethyl phosphite After the reaction is completed, the temperature is lowered, and the crude product is obtained after post-treatment, and the active ester of ceftazidime side chain acid is obtained after refining, with a yield of 95.1% and a purity of 99%. The first mother liquor of the crude product was recovered and concentrated to obtain 25 g of concentrated waste residue, No. 1.

[0036] Add 31.2g of ceftazidime side chain acid active ester and 25g of 7-APCA to 25ml of methanol and 100ml of dichloromethane mixed solvent under control of 0-10°C, add 12.5ml of triethylamine dropwise, after the heat preservation reaction is completed, filter to obtain ceftazidime tert-butyl Esters, yield 86.5%, purity 97.5%. The second mother liquor o...

Embodiment 2

[0039] Control the temperature around 20°C, add 30g of ceftazidime side chain acid and 30g of DM to the mixture of 100ml of toluene and 50ml of acetonitrile, add 8.0g of aniline, 0.4g of 2-methylpyridine in sequence, and then dropwise add 6.0g of triethyl phosphite After the reaction is completed, the temperature is lowered, and the crude product is obtained after post-treatment, and the active ester of ceftazidime side chain acid is obtained after refining, with a yield of 95.5% and a purity of 99%. The first mother liquor of the crude product was recovered and concentrated to obtain 25 g of concentrated waste residue, No. 1.

[0040] Add 31.2g of ceftazidime side chain acid active ester and 25g of 7-APCA to 25ml of methanol and 100ml of dichloromethane mixed solvent under control of 0-10°C, add 12.5ml of triethylamine dropwise, after the heat preservation reaction is completed, filter to obtain ceftazidime tert-butyl Esters, yield 87.1%, purity 97.9%. The second mother liqu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses original development quality ceftazidime and a medicine preparation thereof. The third-generation cephalosporin antibiotics active ester midbody key technology and industrialization obtains the second prize of National Scientific and Technological Progress Award. The cephalosporin antibiotics active ester belongs to a key factor for influencing the internal quality of the cephalosporin. A preparation method comprises the following steps that (a) mixed solvents are added into ceftazidime side chain acid, dibenzothiazyl disulfide, aniline and 2-picoline; triethyl phosphate is dripped for reaction; (b) a coarse product is refined to obtain ceftazidime side chain acid active ester, and the first mother liquid is recovered; (c) the material is added into a mixed solvent for neutralizing 7-APCA; triethylamine is dripped; the temperature reduction is performed for crystal separation and filtering to obtain ceftazidime tert-butyl ester; the second mother liquid is recovered; (d) the ceftazidime tert-butyl ester is subjected to hydrolysis and purification, and then, the ceftazidime is obtained. The original development quality ceftazidime has the advantages that high-toxicity triphenylphosphine is not used; waste liquid and waste slag can be sufficiently recovered and reutilized; the method is safe; the cost is low; the yield is high; the industrial production is facilitated.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to ceftazidime and a pharmaceutical preparation thereof. Background technique [0002] Ceftazidime is an antibiotic with outstanding efficacy against Pseudomonas aeruginosa. It is one of the important third-generation semi-synthetic cephalosporin antibiotics. It has the characteristics of strong bactericidal power and wide antibacterial spectrum. It is widely used clinically. One of the newest and best-selling cephalosporins on the market. [0003] At present, the synthetic method of ceftazidime is mainly to use ceftazidime side chain acid as raw material, react with dibenzothiazole disulfide (DM) under the catalysis of organic base, generate ceftazidime side chain acid active ester; Then react with 7-amino-3 -(1-pyridylmethyl)cephemic acid (7-APCA) was prepared through a series of reactions to ceftazidime. [0004] Jincheng Pharmaceutical's "key technology of active ester inter...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D501/46C07D501/04A61K31/546A61K9/14A61P31/04
CPCA61K9/0019A61K9/14A61K31/546C07D501/04C07D501/46
Inventor 傅苗青赵叶青孙滨许蕾朱旭伟马庆双周白水王雷
Owner 广东金城金素制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products